UPDATE 1-Eli Lilly, AbCellera Biologics to co-develop coronavirus therapies

Eli Lilly Co and privately-held AbCellera Biologics Inc on Thursday announced they would co-develop antibody products for the treatment and prevention of COVID-19, a flu-like disease caused by the fast-spreading coronavirus.

from Reuters: Company News https://ift.tt/2TZM1MB